Related Experiment Videos
A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction
James M Brophy1, Gilles R Dagenais, Frances McSherry
1Division of Cardiology and Clinical Epidemiology, McGill University Health Center, Montréal, Quebec, Canada. jbroph@po-box.mcgill.ca
The American Journal of Medicine
|February 27, 2004
Summary
Predicting heart failure outcomes is crucial. A new model uses routine clinical data to forecast mortality in patients on angiotensin-converting enzyme (ACE) inhibitors, aiding treatment decisions.
Area of Science:
- Cardiology
- Clinical Research
- Medical Statistics
Background:
- Heart failure significantly contributes to illness and death.
- Existing models lack reliability for predicting outcomes in patients using angiotensin-converting enzyme (ACE) inhibitors.
- Predictive tools are needed for patients with heart failure and systolic dysfunction on ACE inhibitors.
Purpose of the Study:
- To develop and validate a statistical model for predicting mortality in heart failure patients receiving ACE inhibitors.
- To identify key clinical variables associated with short- and long-term survival.
Main Methods:
- A multivariate statistical model was created using data from 4277 patients in the Digitalis Investigation Group trial.
- The model was validated on a separate group of 2145 patients.
- Included patients had reduced ejection fraction (
Main Results:
- 12-month mortality was 11.2% and 36-month mortality was 29.9% in the derivation sample.
- Factors predicting reduced survival included lower ejection fraction, impaired renal function, cardiomegaly, worse functional class, heart failure symptoms, lower blood pressure, and lower BMI.
- The model accurately predicted mortality in the validation group. Age and nitrate use also predicted 36-month mortality.
Conclusions:
- Routine clinical variables effectively predict both short- and long-term mortality.
- This model offers a reliable tool for managing heart failure patients on ACE inhibitors.
- Clinical data can guide prognostic assessments in this patient population.